NASDAQ:IPHA
Innate Pharma S.A.
- Stock
Last Close
1.93
02/05 08:31
Market Cap
163.52M
Beta: 0.32
Volume Today
18.96K
Avg: 17.77K
PE Ratio
−1.87
PFCF: −9.30
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -19.65M - | -6.71M 65.87% | 12.64M 288.49% | -48.38M 482.79% | 3.05M 106.30% | -20.76M 780.85% | -63.98M 208.22% | -52.81M 17.47% | -58.10M 10.02% | -7.57M 86.97% | |
depreciation and amortization | 2.34M - | 2.65M 13.27% | 3.26M 22.90% | 4.39M 34.63% | 7.40M 68.47% | 16.53M 123.33% | 56.80M 243.62% | 4.60M 91.91% | 45.41M 887.92% | 5.09M 88.79% | |
deferred income tax | -78K - | -586K 651.28% | -2.61M 346.08% | 3.17M 221.31% | 1.16M 63.58% | -4.14M 458.79% | 2.65M 164.02% | -1.68M 163.40% | |||
stock based compensation | 377K - | 1.01M 168.17% | 1.03M 1.98% | 9.83M 853.35% | 2.71M 72.46% | 3.83M 41.34% | 2.48M 35.31% | 2.62M 5.74% | 4.25M 62.36% | ||
change in working capital | -1.30M - | 211.49M 16,368.54% | -50.79M 124.01% | -16.98M 66.57% | -47.10M 177.36% | 40.25M 185.46% | -49.20M 222.26% | -9.88M 79.91% | -12.50M 26.49% | -32.09M 156.69% | |
accounts receivables | -2.07M - | -22.92M - | 3.39M 114.81% | -4.20M 223.87% | |||||||
inventory | 25.38M - | -6.27M 124.71% | |||||||||
accounts payables | 1.66M - | 9.23M 457.33% | 7.89M 14.57% | 1.39M - | -6.53M 571.34% | -946K 85.51% | -7.66M 709.94% | ||||
other working capital | -883K - | 202.26M 23,005.55% | -58.68M 129.01% | -16.98M 71.06% | -47.10M 177.36% | 38.86M 182.51% | -45.14M 216.16% | -6.06M 86.57% | -636K 89.50% | ||
other non cash items | 170K - | 47K 72.35% | -383K 914.89% | -88K 77.02% | 253K 387.50% | -774K 405.93% | -544K 29.72% | -1.29M 138.05% | 1.80M 238.76% | 2.01M 11.96% | |
net cash provided by operating activities | -18.13M - | 207.91M 1,246.53% | -36.85M 117.72% | -48.06M 30.42% | -32.53M 32.31% | 34.92M 207.36% | -51.81M 248.34% | -58.46M 12.84% | -19.15M 67.23% | -32.56M 69.98% | |
investments in property plant and equipment | -2.34M - | -7.40M 215.71% | -9.39M 26.98% | -6.03M 35.85% | -1.43M 76.29% | -65.40M 4,476.70% | -11.28M 82.75% | -1.33M 88.21% | -1.12M 15.64% | -2.35M 109.80% | |
acquisitions net | -60K - | 8.04M - | 3.06M 61.93% | 9K - | 7K 22.22% | 150K - | |||||
purchases of investments | -1.96M - | -121.87M 6,108.20% | -18.15M 85.10% | -43.27M 138.36% | -3M - | 1K - | |||||
sales maturities of investments | 541K - | 6.97M 1,187.80% | 88.06M 1,163.92% | 19.84M 77.47% | 25.66M 29.36% | 2M 92.21% | -9K 100.45% | 3M - | 22.77M 658.93% | ||
other investing activites | 2K - | -8.04M - | -3.06M 61.93% | 46K 101.50% | 1.28M 2,682.61% | 912K 28.75% | 406K 55.48% | -1K 100.25% | 67K 6,800% | ||
net cash used for investing activites | -3.82M - | -122.30M 3,098.98% | 60.51M 149.48% | -29.46M 148.69% | 24.28M 182.41% | -62.12M 355.86% | -13.37M 78.48% | -917K 93.14% | 1.88M 304.69% | 20.63M 999.15% | |
debt repayment | -613K - | -452K 26.26% | -685K 51.55% | -1.20M 75.47% | -1.34M 11.73% | -1.98M 47.58% | -2.20M 11.20% | -2.07M 6.13% | -2.03M 2.08% | -2.36M 16.54% | |
common stock issued | 47.78M - | 125K 99.74% | 14K 88.80% | 62.56M - | 66.01M 5.51% | 49K 99.93% | 499K 918.37% | 198K 60.32% | 395K 99.49% | ||
common stock repurchased | -70K - | ||||||||||
dividends paid | -850K - | ||||||||||
other financing activites | 1.70M - | 3.36M 97.82% | 69K 97.95% | 2.12M 2,968.12% | 8K 99.62% | 13.74M 171,662.50% | 1.02M 92.58% | 28.39M 2,685.87% | |||
net cash used provided by financing activities | 47.95M - | 3.03M 93.68% | -602K 119.85% | 915K 251.99% | 61.22M 6,590.93% | 77.77M 27.02% | -1.14M 101.46% | 26.82M 2,460.74% | -1.83M 106.82% | -1.97M 7.55% | |
effect of forex changes on cash | -68K - | -63K 7.35% | -23K 63.49% | 66K 386.96% | -26K 139.39% | 5K 119.23% | 219K 4,280% | -483K 320.55% | -428K 11.39% | ||
net change in cash | 25.93M - | 88.58M 241.68% | 23.04M 74.00% | -76.54M 432.26% | 52.95M 169.18% | 50.57M 4.48% | -66.09M 230.69% | -33.04M 50.02% | -19.53M 40.88% | -13.62M 30.26% | |
cash at beginning of period | 38.36M - | 64.29M 67.59% | 152.87M 137.80% | 175.91M 15.07% | 99.37M 43.51% | 152.31M 53.28% | 202.89M 33.20% | 136.79M 32.58% | 103.76M 24.15% | 84.22M 18.82% | |
cash at end of period | 64.29M - | 152.87M 137.80% | 175.91M 15.07% | 99.37M 43.51% | 152.31M 53.28% | 202.89M 33.20% | 136.79M 32.58% | 103.76M 24.15% | 84.22M 18.82% | 70.61M 16.17% | |
operating cash flow | -18.13M - | 207.91M 1,246.53% | -36.85M 117.72% | -48.06M 30.42% | -32.53M 32.31% | 34.92M 207.36% | -51.81M 248.34% | -58.46M 12.84% | -19.15M 67.23% | -32.56M 69.98% | |
capital expenditure | -2.34M - | -7.40M 215.71% | -9.39M 26.98% | -6.03M 35.85% | -1.43M 76.29% | -65.40M 4,476.70% | -11.28M 82.75% | -1.33M 88.21% | -1.12M 15.64% | -2.35M 109.80% | |
free cash flow | -20.48M - | 200.51M 1,079.22% | -46.24M 123.06% | -54.09M 16.96% | -33.96M 37.21% | -30.48M 10.26% | -63.09M 107.01% | -59.79M 5.23% | -20.28M 66.09% | -34.91M 72.18% |
All numbers in USD (except ratios and percentages)